The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multiphase continuing education and quality improvement initiative to tailor treatment plans for patients with follicular lymphoma.
 
Joseph Kim
No Relationships to Disclose
 
Timothy S. Fenske
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca/MedImmune; BeiGene; Biogen; Bristol-Myers Squibb; CSL Limited; Karyopharm Therapeutics; Kite, a Gilead Company; Kyowa Kirin; MorphoSys; Pharmacyclics; Sanofi; SERVIER; TG Therapeutics; Verastem
Research Funding - Curis (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Linda Gracie-King
Stock and Other Ownership Interests - Exelixis (I)
 
Marc David Viens
Employment - Lundbeck (I)
 
Victor Ocana
No Relationships to Disclose
 
Abhinav Binod Chandra
Stock and Other Ownership Interests - Acceleron Pharma; Agios; Bluebird Bio; Genprex; Illumina; IQvia; Karyopharm Therapeutics; Karyopharm Therapeutics (I); Molecular Templates; Pacific Biosciences; Quintiles; ZIOPHARM Oncology
Consulting or Advisory Role - Tempus
 
David Penberthy
Employment - AstraZeneca/Merck; Radiation Oncology Associates
Stock and Other Ownership Interests - Community Health Systems
Honoraria - AstraZeneca/Merck
Speakers' Bureau - AstraZeneca/Merck
Other Relationship - Association of Community Cancer Centers (ACCC)
 
Tori McCurdy
No Relationships to Disclose